Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
BEAM
BEAM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest BEAM ETF News Today | Earnings, Events & Price Alerts
BEAM News
Beam Therapeutics Stock Soars to New Heights
Feb 24 2026
Benzinga
Beam Therapeutics Reports Q4 Earnings Exceeding Expectations
Feb 24 2026
seekingalpha
Beam Therapeutics Executive Sells Shares
Feb 01 2026
Fool
Wall Street Focuses on Earnings and Commodity Prices
Jan 29 2026
stocktwits
ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares
Jan 19 2026
seekingalpha
BEAM Options Analysis: Put Contract Offers 11.29% YieldBoost
Jan 13 2026
NASDAQ.COM
Beam Therapeutics (BEAM) to Submit Biologics License Application for Risto-cel by End of 2026
Jan 12 2026
stocktwits
Beam Therapeutics Outlines 2026 Strategy, Shares Surge 23.67%
Jan 12 2026
Benzinga
Bank Stocks Decline Broadly; Capital One Drops 6% Following Trump's Rate Cap Proposal
Jan 12 2026
CNBC
Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%
Jan 12 2026
Benzinga
Beam Therapeutics (BEAM) Shares Surge 19% on Progress in Genetic Medicines and $1.25 Billion Cash
Jan 12 2026
seekingalpha
Beam Therapeutics (BEAM) to Report BEAM-302 Trial Data by Q1 2026
Jan 12 2026
NASDAQ.COM
Beam Therapeutics Aligns with FDA on Accelerated Approval Pathway for BEAM-302
Jan 11 2026
Globenewswire
Beam Therapeutics Aligns with FDA on Accelerated Approval Pathway for BEAM-302
Jan 11 2026
Yahoo Finance
BEAM Options Analysis: $29 Put Contract Offers 10.17% YieldBoost
Jan 06 2026
NASDAQ.COM
U.S. Stocks Rise as Microchip Technology Raises Q3 Revenue Outlook to $1.185 Billion
Jan 06 2026
Benzinga
Show More News
